Sinopharm
1099.HK
£1.77
Share price
1.01%
Change (1 day)
-12.50%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Revenue for Sinopharm (1099.HK)
Revenue in 2023 (TTM): £52.27 Billion
According to Sinopharm's latest financial reports the company's current revenue (TTM 
) is £64.37 Billion. an increase over the revenue in the year 2022 that were of £61.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sinopharm from 2006 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | £64.37 B | 5.42% |
| 2022 | £61.06 B | -2.1% |
| 2021 | £62.37 B | 16.85% |
| 2020 | £53.37 B | 14.95% |
| 2019 | £46.43 B | 21.52% |
| 2018 | £38.21 B | 5.93% |
| 2017 | £36.07 B | 27.22% |
| 2016 | £28.35 B | 5.37% |
| 2015 | £26.90 B | 9.14% |
| 2014 | £24.65 B | 17.22% |
| 2013 | £21.03 B | 25.94% |
| 2012 | £16.69 B | 34.61% |
| 2011 | £12.40 B | 55.34% |
| 2010 | £7.98 B | 35.79% |
| 2009 | £5.88 B | 37.56% |
| 2008 | £4.27 B | 31.43% |
| 2007 | £3.25 B | 40.26% |
| 2006 | £2.31 B |